Search This Blog

Monday, May 4, 2026

Lilly shares under pressure after serious Foundayo adverse effects

 Eli Lilly stock dips after FAERS reports liver failure tied to obesity drug Foundayo (orforglipron). 

https://seekingalpha.com/news/4584738-lilly-shares-under-pressure-after-serious-foundayo-adverse-event-report

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.